Troup Gordon A Insider Trades

Insider Trading History

Track insider trading activity for Troup Gordon A. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Navidea Biopharmaceuticals
Navidea Biopharmaceuticals NAVB
Director
Holding Value $26.6 265,568 shares
Last Trade
Apr 20, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$734k 28,000 shares
$26.20
$0.00
Navidea Biopharmaceuticals
Navidea Biopharmaceuticals NAVB
Director
Holding Value $23.8 237,568 shares
Last Trade
Oct 09, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$235k 5,254 shares
$44.80
$0.00
Navidea Biopharmaceuticals
Navidea Biopharmaceuticals NAVB
Director
Holding Value $23.2 232,314 shares
Last Trade
Jul 26, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$370k 10,559 shares
$35.00
$0.00
Navidea Biopharmaceuticals
Navidea Biopharmaceuticals NAVB
Director
Holding Value $22.2 221,715 shares
Last Trade
May 29, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$250k 10,000 shares
$25.00
$0.00
Navidea Biopharmaceuticals
Navidea Biopharmaceuticals NAVB
Director
Holding Value $21.2 211,755 shares
Last Trade
Mar 26, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$726k 22,000 shares
$33.00
$0.00
Navidea Biopharmaceuticals
Navidea Biopharmaceuticals NAVB
Director
Holding Value $19 189,755 shares
Last Trade
Feb 05, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$246k 7,406 shares
$33.20
$0.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up